Identifikatu
Taldeak
Ikertzaileak
Emaitzak
HOSPITAL UNIVERSITARIO RUBER
Saila
University of Nottingham
Nottingham, Reino Unido
Hemen zaude
Lankidetzak
University of Nottingham
University of Nottingham-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2023
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10371, pp. 105-117
Kontaktua
Lege-oharra
Laguntza
translate
eu
arrow_drop_down
translate
eu
arrow_drop_down
es
ca
gl
en
fr
de